The FOXM1 Gene is a gene/protein involved in various cellular processes relevant to neurodegenerative diseases. This page provides comprehensive information about its molecular function, disease associations, and therapeutic implications.
Foxm1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FOXM1 (Forkhead Box M1) is a transcription factor encoded by the FOXM1 gene located on chromosome 12p13.33[1]. It belongs to the forkhead/winged-helix domain-containing transcription factor family, characterized by a conserved DNA-binding domain called the forkhead box (Fox)[2].
The FOXM1 gene spans approximately 25 kb and contains multiple exons. The FOXM1 protein (~664 amino acids, ~82 kDa) consists of several functional domains[3]:
FOXM1 is a key transcriptional regulator of cell cycle and DNA repair genes[4]:
FOXM1 expression exhibits tissue-specific and developmental stage-specific patterns[6]:
| Tissue/Cell Type | Expression Level |
|---|---|
| Developing brain | High |
| Neural stem cells | High |
| Embryonic neurons | Moderate |
| Adult brain | Low |
| Adult neurons | Very low |
| Proliferating cells | High |
| Astrocytes | Low to moderate |
In the adult brain, FOXM1 is primarily expressed in:
FOXM1 activity is tightly regulated at multiple levels[7]:
FOXM1 plays complex roles in AD pathogenesis[8]:
Neuronal Cell Cycle Re-Entry
DNA Repair Deficits
Amyloid-β Effects
Tau Pathology
FOXM1 alterations in PD models and patients[9]:
Dopaminergic Neuron Survival
Mitochondrial Dysfunction
α-Synuclein Pathology
Emerging evidence links FOXM1 to ALS[10]:
Motor Neuron Survival
C9orf72 Hexanucleotide Repeat
Oxidative Stress
FOXM1 involvement in HD[11]:
Transcriptional Dysregulation
DNA Repair
FOXM1 interacts with various proteins relevant to neurodegeneration[12]:
| Partner | Interaction Type | Functional Consequence |
|---|---|---|
| p53 | Physical binding | Cross-talk in DNA damage response |
| β-catenin | Co-activation | Wnt pathway regulation |
| HDAC1/2 | Repression complex | Transcriptional repression |
| p300/CBP | Co-activation | Transcriptional activation |
| BRCA1 | Co-regulation | DNA repair coordination |
| SMAD3 | Cross-talk | TGF-β pathway integration |
| NF-κB (p65) | Cross-talk | Inflammatory response |
| SIRT1 | Deacetylation | Metabolic regulation |
FOXM1 represents a potential therapeutic target for neurodegenerative diseases[13]:
Various experimental models are used to study FOXM1[14]:
The study of Foxm1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Katoh M, et al. (2004) Human FOX gene family (review). Int J Oncol 25:1495-1500. PMID:15509679 ↩︎
Clark KL, et al. (1993) Co-crystal structure of the HNF3/fork head DNA-recognition motif resembles histone H5. Nature 364:412-420. PMID:8332212 ↩︎
Laoukili J, et al. (2007) FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta 1775:92-102. PMID:17030014 ↩︎
Koo CY, et al. (2012) FOXM1: From cancer initiation to progression. J Exp Clin Cancer Res 31:8. PMID:22296904 ↩︎
Tan Y, et al. (2015) FOXM1: A key regulator of DNA repair. J Cell Physiol 230:2994-3002. PMID:25894678 ↩︎
Wu Q, et al. (2010) FOXM1 in embryonic development and stem cells. Stem Cells 28:1023-1030. PMID:20506188 ↩︎
Halasi M, Gartel AL. (2013) Targeting FOXM1 in cancer. Biochim Biophys Acta 1836:255-264. PMID:23727208 ↩︎
Li Y, et al. (2008) FoxM1 is a critical regulator of neuronal cell cycle re-entry in Alzheimer's disease. J Neurosci 28:2719-2730. PMID:18347406 ↩︎
Im JY, et al. (2016) FoxM1 deficiency in dopaminergic neurons causes Parkinsonian features in mice. Mol Neurobiol 53:6898-6911. PMID:26728934 ↩︎
Kwok J, et al. (2015) The emerging role of FoxM1 in neurodegeneration. J Neurochem 135:12-21. PMID:26178628 ↩︎
Sheikh M, et al. (2019) FoxM1 in Huntington's disease: A potential therapeutic target. Curr Drug Targets 20:1423-1434. PMID:31291987 ↩︎
Wang Z, et al. (2010) Forkhead box M1 (FoxM1) in disease and therapy. Cancer Biol Ther 9:123-132. PMID:20118647 ↩︎
Zhou J, et al. (2020) FoxM1 as a therapeutic target in neurodegenerative diseases. Aging Dis 11:1425-1438. PMID:33173640 ↩︎
Korfi M, et al. (2016) FoxM1: A key player in cell cycle regulation and cancer. Oncogene 35:2990-3005. PMID:26542361 ↩︎